Further validation of the Cognitive Biases Questionnaire for psychosis

Abstract

Background Cognitive biases are recognized as important treatment targets for reducing symptoms associated with severe mental disorders. Although cognitive biases have been linked to symptoms in most studies, few studies have looked at such biases transdiagnostically. The Cognitive Bias Questionnaire for psychosis (CBQp) is a self-reported questionnaire that assesses cognitive biases amongst individuals with a psychotic disorder, as well as individuals with other severe mental disorders. The current study aims to validate a French version of the CBQp and to explore transdiagnostic cognitive biases in individuals with psychotic disorders, individuals with depression, and in healthy controls. Methods The CBQp was translated into French following a protocol based on international standards. Discriminant validity and internal consistency were determined for total score and each subscale score. Confirmatory factor analyses were performed to test construct validity. Finally, cluster analyses were conducted to investigate cognitive biases across diagnostic groups. Results Our results were similar to those of the original authors, with the one-factor solution (assessment of a general thinking bias) being the strongest, but the two-factor solution (assessing biases within two themes relating to psychosis) and the five-factor solution (assessment of multiple distinct biases) being clinically more interesting. A six-cluster solution emerged, suggesting that individuals with similar diagnoses score differently on all cognitive biases, and that individuals with different diagnoses might have similar cognitive biases. Conclusions The current findings support the validity of the French translation of the CBQp. Our cluster analyses overall support the transdiagnostic presence of cognitive biases.

Transdiagnostic cognitive biases in psychiatric disorders: A systematic review and network meta-analysis

“…Several studies reported means for several diagnoses combined together into broader categories, for example, anxiety disorders (De Cort et al, 2008;Lichtenstein-Vidne et al, 2017;Neng and Weck, 2015), depressive disorders (Duddu et al, 2003;Wittorf et al, 2012), and schizophrenia-spectrum disorders (Krkovic et al, 2023;Samson et al, 2022;Wittorf et al, 2012;Zhu et al, 2020), thus limiting the feasible categories for network meta-analysis.…”